Skip to main content
SpringerLink
Log in
Book cover

Aktuelle Neuropädiatrie 1990 pp 392–404Cite as

Medikamentöse Therapie neuromuskulärer Erkrankungen

  • Conference paper

  • 38 Accesses

Zusammenfassung

Aus der großen Gruppe neuromuskulärer Krankheiten können nur einige der Erkrankungen, d.h. die Duchenne’sche Muskeldystrophie, die Myasthenia gravis, die Dermatomyositis und die Mitochondriozytopathien herausgegriffen und ihre möglichen medikamentösen Therapien dargestellt werden. Auf andere Entitäten dieses Formenkreises, wie die übrigen Spielarten der Muskeldystrophien, auf die spinalen Muskelatrophien, die maligne Hyperthermie, die verschiedenen myotonen Erkrankungen kann hier nicht eingegangen werden.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Albers JW, Faulkner JA, Dorovini-Zis K et al. (1984) Abnormal neuromuscular transmission in an infantile myasthenic syndrome. Ann Neurol 16: 28–34

    Article  PubMed  CAS  Google Scholar 

  • Argov Z, Bank WJ, Maris Jet al. (1986) Treatment of mitochondrial myopathy due to complex IIl deficiency with vitamins K3 and C: a 31P NMR follow-up study. Ann Neurol 19: 598–602

    Article  PubMed  CAS  Google Scholar 

  • Bäckman E, Nylander E, Johansson I et al. (1988) Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function. Acta Neurol Scand 78: 429–435

    Google Scholar 

  • Barnard PJ, Barnard EP (1980) Chemotherapy in the genetically dystrophic chicken with a neurotrophic drug with serotonin antagonists. In: Angelini et al. (eds) Muscular dystrophy research: advances and trends. Excerpta Medica Amsterdam, pp 242–248

    Google Scholar 

  • Bertorini TE, Bhattacharya SK, Palmieri GM et al. (1982) Muscle calcium and magnesium content in Duchenne muscular dystrophy. Neurology (NY) 32: 1088–1092

    CAS  Google Scholar 

  • Bertorini TE, Palmieri GMA, Griffin JW et al. (1988) Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy. Neurology 38: 609–613

    PubMed  CAS  Google Scholar 

  • Bodensteiner JB, Engel AG (1978) Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567.000 muscle fibers in 114 biopsies. Neurology (Minneap) 28: 439–446

    CAS  Google Scholar 

  • Bohan A. Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292: 344–347, 403–407

    Article  Google Scholar 

  • Bohan A, Peter JB, Bowman RRL (1977) A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 56: 255–286

    Article  PubMed  CAS  Google Scholar 

  • Bondoux-Jahan M, Hügelin A (1982) Acceleration par l’isaxonine du bourgeonnement collateral au niveau du muscle partiellement denerve. Nouv Presse Med 11: 1243–1245

    PubMed  CAS  Google Scholar 

  • Brambati B, Cornelio F, Dworzak F, Dones I (1980) Calcium-positive muscle fibers in fetuses at risk for Duchenne muscular dystrophy Lancet II: 969–970

    Google Scholar 

  • Bresolin N. Bet L, Binda A et al. (1988) Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme QIO. Neurology 38: 892–899

    PubMed  CAS  Google Scholar 

  • Brooke MH, Griggs RC, Mendell JR et al. (1981) Clinical trial in Duchenne dystrophy: I. The design of the protocol. Muscle Nerve 4: 186–187

    Google Scholar 

  • Brooke MH, Fenichel GM, Griggs RC et al. (1983) Clinical investigation in Duchenne dystrophy: II. Determination of the “power” of therapeutic trials based on the natural history. Muscle Nerve 6: 91–103

    Article  PubMed  CAS  Google Scholar 

  • Brooke MH, Fenichel GM, Griggs RC et al. (1987) Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone. Arch Neurol 44: 812–817

    PubMed  CAS  Google Scholar 

  • Bunch TW (1981) Prednisone and azathioprine for polymyositis: long-term follow up. Arthritis Rheum 24: 45–48

    Article  PubMed  CAS  Google Scholar 

  • Bunch TW, Worthington JW, Combs JJ et al. (1980) Azathioprine with prednisone for polymyositis. A con trolled, clinical trial. Ann Intern Med 92: 365–369

    PubMed  CAS  Google Scholar 

  • Chan-Lui WY, Hawkins BR (1985) Infantile myasthenia. Neuropediatrics 16: 24–28

    Article  PubMed  CAS  Google Scholar 

  • DeSilva S, Drachman DB, Mellits D, Kund R (1987) Prednisone treatment in Duchenne muscular dystrophy. Long term benefit. Arch Neurol 44: 818–822

    PubMed  CAS  Google Scholar 

  • Drachman DB, Toyka KV, Myer E (1974) Prednisone in Duchenne muscular dystrophy. Lancet II: 1409–1412

    Google Scholar 

  • Dubowitz V, Heckmatt JZ (1980) Management of muscular dystrophy: pharmacological and physical aspects. Br Med Bull 36: 139–144

    PubMed  CAS  Google Scholar 

  • Engel AG, Lambert EH, Gomez MR (1977) A new myasthenic syndrome with endplate acetylcholine-esterase deficiency, small nerve terminals and reduced acetylcholine release. Ann Neurol 1: 315–330

    Article  PubMed  CAS  Google Scholar 

  • Engel AG, Lambert EH, Mulder DM et al. (1982) A newly recognised congenital myasthenic syndrome attributed as a prolonged open-time of the acetylcholine-induced ion channel. Ann Neurol 11: 553–569

    Article  PubMed  CAS  Google Scholar 

  • Fenichel GM, Brooke MH, Griggs RC et al. (1988) Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E. Muscle Nerve 11: 1164–1168

    Article  CAS  Google Scholar 

  • Fitzgerald G, McArdle B (1941) Vitamins E and B6 in the treatment of muscular dystrophy and motor neurone disease. Brain 64: 19–42

    Google Scholar 

  • Gamstorp I, Gustaysson KH, Hellström O, Nordgren B (1986) A trial of selenium and vitamin E in boys with muscular dystrophy. J Child Neurol 1: 211–214

    CAS  Google Scholar 

  • Gieron MA, Korthals JK (1985) Familial infantile myasthenia gravis. Arch Neurol 42: 143–144

    PubMed  CAS  Google Scholar 

  • Girardin E, Dayer JM, Paunier L (1988) Cyclosporin for juvenile dermatomyositis. J Pediatr 112: 165–166

    PubMed  CAS  Google Scholar 

  • Goda S, Hamada T, Ishimoto S et al. (1987) Clinical improvement after administration of coenzyme Q10 in a patient with mitochondrial encephalomyopathy. J Neurol 234: 62–63

    Article  PubMed  CAS  Google Scholar 

  • Hart Z, Sahashi K. Lambert EH et al. (1979) A congenital familial myasthenic syndrome caused by a presynaptic defect of transmitter resynthesis or mobilisation. Neurology 29: 556–557

    Google Scholar 

  • Heckmatt JZ, Hyde SA, Gabain A, Dubowitz V (1988) Therapeutic trial of isaxonine in Duchenne muscular dystrophy. Muscle Nerve 11: 836–847

    Article  PubMed  CAS  Google Scholar 

  • Heckmatt J, Saunders C, Peters AM et al. (1989) Cyclosporin in juvenile dermatomyositis. Lancet I: 1063–1066

    Google Scholar 

  • Hugelin A, Legrain Y, Bondous-Jahan M (1979) Nerve growth promoting action of isaxonine in rat. Experientia 35: 626

    Article  PubMed  CAS  Google Scholar 

  • Jacobs JC (1977) Methotrexate and azathioprine treatment of childhood dermatomyositis. Pediatrics 59: 212–218

    PubMed  CAS  Google Scholar 

  • Keesey J, Lindstrom J, Cokely H, Hermann C (1977) Anti-acetylcholine receptor antibody in neonatal myasthenia gravis. N Engl J Med 296: 55

    PubMed  CAS  Google Scholar 

  • Langsjoen PH, Folkers K, Lyson K et al. (1988) Effective and safe therapy with coenzyme Q10 for cardiomyopathy. Klin Wochenschr 66: 583–590

    Article  PubMed  CAS  Google Scholar 

  • Law PK, Goodwin TG, Wang MG (1988) Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle Nerve 11: 525–533

    Article  PubMed  CAS  Google Scholar 

  • Law PK, Bertorini TE, Goodwin JA et al. (1990a) Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet II: 114

    Google Scholar 

  • Law PK, Fang R, Goodwin JA et al. (1990b) First clinical trial of myoblast transfer therapy. J Neurol Sci 98 (Suppl): 32

    Google Scholar 

  • Lecky BRF, Morgan-Hughes JA, Murray NMF et al. (1986) Congenital myasthenia: further evidence of disease heretogeneity. Muscle Nerve 9: 233–242

    Article  PubMed  CAS  Google Scholar 

  • Lefvert AK, Osterman PO (1983) Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine-receptor antibodies in 17 children. Neurology 33: 133–138

    PubMed  CAS  Google Scholar 

  • Malleson PN, Ansell BM, Miller J, Pachman LM, Sullivan DB (1990) Controversies in juvenile dermatomyositis. J Rheumatol 17 (Suppl 22): 1–6

    Google Scholar 

  • Mendell JR, Province MA, Moxley RT (1987) Clinical investigation of Duchenne muscular dystrophy. Arch Neurol 44: 808–811

    PubMed  CAS  Google Scholar 

  • Mendell JR, Moxley RT, Griggs RC et al. (1989) Randomized, double-blind six-month trial of prednisone in Duchenne’s muscular dystrophy. N Engl J Med 320: 1592–4597

    Article  PubMed  CAS  Google Scholar 

  • Morel E, Eymard B, Vernet-der-Garabedian B et al. (1988) Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30 cases. Neurology 38: 138–142

    PubMed  CAS  Google Scholar 

  • Moxley RT, Brooke MH, Fenichel GM et al. (1987) Clinical investigation in Duchenne dystrophy. VI. Double-blind controlled trial of nifedipine. Muscle Nerve 10: 22–33

    Google Scholar 

  • Nakao K, Nishitani H, Susuki M, Ohta M, Hayashi K (1977) Anti-acetylcholine receptor IgG in neonatal myasthenia gravis. N Engl J Med 297: 169

    Article  PubMed  CAS  Google Scholar 

  • Namba T, Brown SB, Grob D (1970) Neonatal myasthenia gravis: report of two cases and review of literature. Pediatrics 45: 488–505

    PubMed  CAS  Google Scholar 

  • Niakan E, Pitner SE, Whitaker JN (1980) Immunosuppressive agents in corticosteroidrefractory childhood dermatomyositis. Neurology 30: 286–291

    PubMed  CAS  Google Scholar 

  • Nishikawa Y, Takahashi M, Yorifuji S et al. (1989) Long-term coenzyme 010 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study. Neurology 39: 399–403

    PubMed  CAS  Google Scholar 

  • Ogasahara S, Nishikawa Y, Yorifuji S et al. (1986) Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology 36: 45–53

    PubMed  CAS  Google Scholar 

  • Ohta K, Muzuno Y (1988) Pathogenesis of progressive muscular dystrophy: studies on free radical metabolism in an animal model. Acta Neurol Scand 77: 108–114

    Article  PubMed  CAS  Google Scholar 

  • Pachman LM (1986) Juvenile dermatomyositis. Pediatr Clin North Am 33: 1097–1117

    PubMed  CAS  Google Scholar 

  • Pernice W, Beckmann R, Ketelsen UP et al. (1988) A double-blind placebo controlled trial of diltiazem in Duchenne dystrophy. Klin Wochenschr 66: 565–570

    Article  PubMed  CAS  Google Scholar 

  • Przyrembel H (1987) Therapy of mitochondrial disorders. J Inher Metabol Dis 10: 129–146

    Article  Google Scholar 

  • Roach ES, Buono G, McLean W, Weaver RG (1986) Early-onset myasthenia gravis. J Pediatr 108: 193–197

    Article  PubMed  CAS  Google Scholar 

  • Robinson BH, Taylor J, Francois B, Beaudet AL, Peterson DF (1983) Lactic acidosis, neurological deterioration and compromised cellular pyruvate oxidation due to a defect in the reoxidation of cytoplasmically generated NADH. Eur J Pediatr 140: 98–101

    Article  PubMed  CAS  Google Scholar 

  • Shay JW, Feit H (1980) Avian muscular dystrophy: microtubules, righting ability, CPK levels and muscle histology following isaxonine treatment. Eur J Cell Biol 22: 557

    Google Scholar 

  • Siegel IM, Miller JE, Ray RD (1974) Failure of corticosterone in the treatment of Duchenne muscular dystrophy: Report of a clinically matched three-year double blind study. IMJ 145: 32–36

    Google Scholar 

  • Vincent A, Cull-Candy SG, Newsom-Davis J et al. (1981) Congenital myasthenia: endplate receptors and electrophysiology in five cases. Muscle Nerve 4: 306–318

    Article  PubMed  CAS  Google Scholar 

  • Walton JN, Nattrass FJ (1954) On the classification, natural history and treatment of the myopathies. Brain 77: 169–231

    Article  PubMed  CAS  Google Scholar 

  • Yarom R, Meyer S, More R, Liebergall M, Eldor A (1983) Platelet abnormalities in muscular dystrophy. Thromb Haemost 49: 168–172

    PubMed  CAS  Google Scholar 

  • Yoshida M, Ando K, Stoyoshi E (1983) Abnormalities of erythrocytes in Duchenne muscular dystrophy. Ann Neurol 13: 649–653

    Article  PubMed  CAS  Google Scholar 

  • Zabel P, Leimenstoll G, Gross WL (1984) Cyclosporin for acute dermatomyositis. Lancet 1: 343

    Article  PubMed  CAS  Google Scholar 

  • Zierz S, Jahns G, Jerusalem F (1989) Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus. J Neurol 236: 97–101

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. D. Rating
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kantonsspital Bruderholz, Kinderklinik, CH-4101, Bruderholz, Schweiz

    J. Lütschg

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Rating, D. (1991). Medikamentöse Therapie neuromuskulärer Erkrankungen. In: Lütschg, J. (eds) Aktuelle Neuropädiatrie 1990. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76833-0_58

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76833-0_58

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76834-7

  • Online ISBN: 978-3-642-76833-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation